{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T03:15:56Z","timestamp":1771125356489,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"program of the Conba-Zhejiang Sci-Tech University, Academician Workstation, China","award":["116129A4J14365"],"award-info":[{"award-number":["116129A4J14365"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"crossref","award":["81372453"],"award-info":[{"award-number":["81372453"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"crossref","award":["81572999"],"award-info":[{"award-number":["81572999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China Youth Science Foundation Project, China","award":["31701220"],"award-info":[{"award-number":["31701220"]}]},{"name":"Shanghai Municipal Committee of Science and Technology, China","award":["15431902800"],"award-info":[{"award-number":["15431902800"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.08.036","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T13:51:38Z","timestamp":1534427498000},"page":"2758-2763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2\/M phase arrest and apoptosis promotion"],"prefix":"10.1016","volume":"503","author":[{"given":"Wenjie","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianlong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.08.036_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.08.036_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","article-title":"The evolving epidemiology of hepatocellular carcinoma: a global perspective","volume":"9","author":"Wallace","year":"2015","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2018.08.036_bib3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2014","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2018.08.036_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: clinical frontiers and perspectives","volume":"63","author":"Bruix","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2018.08.036_bib5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2174\/138920112800958869","article-title":"Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a trend in both cancer gene therapy and cancer virotherapy","volume":"13","author":"Liu","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.bbrc.2018.08.036_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/cr.2014.10","article-title":"VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex","volume":"24","author":"Zhang","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2018.08.036_bib7","doi-asserted-by":"crossref","first-page":"14058","DOI":"10.1038\/ncomms14058","article-title":"VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer","volume":"8","author":"Jiao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.08.036_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2011.07.117","article-title":"A\u00a0novel inhibitor of apoptosis protein (IAP)-interacting protein, Vestigial-like (Vgl)-4, counteracts apoptosis-inhibitory function of IAPs by nuclear sequestration","volume":"412","author":"Jin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.08.036_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","article-title":"A\u00a0peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer","volume":"25","author":"Jiao","year":"2014","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2018.08.036_bib10","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1038\/s41598-017-06227-7","article-title":"VGLL4 selectively represses YAP-dependent gene induction and tumorigenic phenotypes in breast cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.08.036_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1525-0016(03)00071-6","article-title":"A\u00a0multitasking oncolytic adenovirus vector","volume":"7","author":"Toth","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2018.08.036_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145272","article-title":"A\u00a0multi targeting conditionally replicating adenovirus displays enhanced oncolysis while maintaining expression of immunotherapeutic agents","volume":"10","author":"Dobbins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.08.036_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2015.10.019","article-title":"Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in\u00a0vitro and in\u00a0vivo","volume":"487","author":"Gomez-Gutierrez","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2018.08.036_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/mt.2011.242","article-title":"Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11","volume":"20","author":"Wong","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2018.08.036_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ymthe.2004.03.017","article-title":"An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency","volume":"9","author":"Liu","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2018.08.036_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/1535-7163.MCT-09-0704","article-title":"A\u00a0novel E1B-55kD-deleted oncolytic adenovirus carrying mutant KRAS-regulated hdm2 transgene exerts specific antitumor efficacy on colorectal cancer cells","volume":"9","author":"Liu","year":"2010","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.08.036_bib17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.onc.1203395","article-title":"The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2","volume":"19","author":"Kratzer","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.08.036_bib18","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/1535-7163.MCT-06-0187","article-title":"Enhanced transduction of malignant glioma with a double targeted Ad5\/3-RGD fiber-modified adenovirus","volume":"5","author":"Tyler","year":"2006","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.08.036_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016152","article-title":"MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity","volume":"6","author":"Cawood","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.08.036_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbrc.2017.07.041","article-title":"A\u00a0novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models","volume":"491","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.08.036_bib21","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/ijc.23853","article-title":"Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression","volume":"123","author":"Morisawa","year":"2008","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2018.08.036_bib22","doi-asserted-by":"crossref","first-page":"18041","DOI":"10.18632\/oncotarget.24710","article-title":"Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer","volume":"9","author":"Salzwedel","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.08.036_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.18632\/oncotarget.1430","article-title":"Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.08.036_bib24","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/mto.2016.31","article-title":"Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model","volume":"3","author":"Yamano","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.bbrc.2018.08.036_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.230","article-title":"RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion","volume":"8","author":"Xu","year":"2017","journal-title":"Cell Death Dis."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18317169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18317169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T21:35:24Z","timestamp":1604784924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18317169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18317169"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.036","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2\/M phase arrest and apoptosis promotion","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}